Montchanin Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $3.95M | Sell |
9,802
-1,620
| -14% | -$652K | 3.83% | 8 |
|
|
2024
Q3 | $5.31M | Buy |
11,422
+685
| +6% | +$319K | 4.9% | 7 |
|
|
2024
Q2 | $5.03M | Sell |
10,737
-242
| -2% | -$113K | 4.76% | 6 |
|
|
2024
Q1 | $4.59M | Buy |
+10,979
| New | +$4.59M | 4.5% | 8 |
|
|
2023
Q2 | $2.44M | Buy |
6,935
+885
| +15% | +$311K | 2.78% | 10 |
|
|
2023
Q1 | $2.06M | Buy |
6,050
+1,975
| +48% | +$673K | 2.61% | 13 |
|
|
2022
Q4 | $1.18M | Buy |
4,075
+300
| +8% | +$86.7K | 1.61% | 15 |
|
|
2022
Q3 | $1.09M | Hold |
3,775
| – | – | 1.55% | 16 |
|
|
2022
Q2 | $1.06M | Buy |
+3,775
| New | +$1.06M | 1.47% | 17 |
|